BUENA, N.J., March 31, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based topical generic pharmaceutical company, will be presenting at the Needham & Company's 13th Annual Healthcare Conference. The Conference will take place on April 8-9, 2014 at the Westin Grand Central Hotel in New York City.
Jason Grenfell-Gardner, CEO and President and Jenniffer Collins, Chief Financial Officer of IGI Laboratories, Inc. will present on Tuesday April 8, 2014 at 3:40 p.m. ET. Investors attending the conferences who wish to meet with Mr. Grenfell-Gardner and Mrs. Collins for a one-on-one meeting should contact their Needham & Company representative directly.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.igilabs.com. A replay will be available for 90 days.
About IGI Laboratories, Inc.IGI Laboratories is a generic topical pharmaceutical company. We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leading player in the generic topical prescription drug market. Logo - http://photos.prnewswire.com/prnh/20130827/MM70487LOGO SOURCE IGI Laboratories, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts